Zobrazeno 1 - 10
of 38
pro vyhledávání: '"van Berkel SS"'
Autor:
van Berkel, SS, Brem, J, Rydzik, AM, Salimraj, R, Cain, R, Verma, A, Owens, RJ, Fishwick, CWG, Spencer, J, Schofield, CJ
Metallo-β-lactamases (MBLs) are a growing threat to the use of almost all clinically used β-lactam antibiotics. The identification of broad-spectrum MBL inhibitors is hampered by the lack of a suitable screening platform, consisting of appropriate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::4bf46c9fc573214e5594c5e0062c5ab8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
de Bever L; Synaffix BV, Kloosterstraat 9, 5349 AB Oss, The Netherlands., Popal S; Synaffix BV, Kloosterstraat 9, 5349 AB Oss, The Netherlands., van Schaik J; Synaffix BV, Kloosterstraat 9, 5349 AB Oss, The Netherlands., Rubahamya B; Department of Chemical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States., van Delft FL; Synaffix BV, Kloosterstraat 9, 5349 AB Oss, The Netherlands., Thurber GM; Department of Chemical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States.; Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States., van Berkel SS; Synaffix BV, Kloosterstraat 9, 5349 AB Oss, The Netherlands.
Publikováno v:
Bioconjugate chemistry [Bioconjug Chem] 2023 Mar 15; Vol. 34 (3), pp. 538-548. Date of Electronic Publication: 2023 Mar 01.
Autor:
Wijdeven MA; Synaffix BV, The Netherlands., van Geel R; Synaffix BV, The Netherlands., Hoogenboom JH; Synaffix BV, The Netherlands., Verkade JMM; Synaffix BV, The Netherlands., Janssen BMG; Synaffix BV, The Netherlands., Hurkmans I; Synaffix BV, The Netherlands., de Bever L; Synaffix BV, The Netherlands., van Berkel SS; Synaffix BV, The Netherlands., van Delft FL; Synaffix BV, The Netherlands.
Publikováno v:
MAbs [MAbs] 2022 Jan-Dec; Vol. 14 (1), pp. 2078466.
Autor:
Salimraj R; School of Cellular and Molecular Medicine, University of Bristol, UK., Hinchliffe P; School of Cellular and Molecular Medicine, University of Bristol, UK., Kosmopoulou M; School of Cellular and Molecular Medicine, University of Bristol, UK., Tyrrell JM; Institute of Infection and Immunity, Cardiff University, UK., Brem J; Department of Chemistry, University of Oxford, UK., van Berkel SS; Department of Chemistry, University of Oxford, UK., Verma A; Oxford Protein Production Facility UK, Rutherford Appleton Laboratory, Oxfordshire, UK., Owens RJ; Oxford Protein Production Facility UK, Rutherford Appleton Laboratory, Oxfordshire, UK., McDonough MA; Department of Chemistry, University of Oxford, UK., Walsh TR; Institute of Infection and Immunity, Cardiff University, UK., Schofield CJ; Department of Chemistry, University of Oxford, UK., Spencer J; School of Cellular and Molecular Medicine, University of Bristol, UK.
Publikováno v:
The FEBS journal [FEBS J] 2019 Jan; Vol. 286 (1), pp. 169-183. Date of Electronic Publication: 2018 Nov 23.
Autor:
van Berkel SS; Synaffix BV, Kloosterstraat 9, 5349 AB, Oss, The Netherlands., van Delft FL; Synaffix BV, Kloosterstraat 9, 5349 AB, Oss, The Netherlands; Wageningen University and Research, Laboratory of Organic Chemistry, Stippeneng 4, 6708 WE, Wageningen, The Netherlands. Electronic address: f.vandelft@synaffix.com.
Publikováno v:
Drug discovery today. Technologies [Drug Discov Today Technol] 2018 Dec; Vol. 30, pp. 3-10. Date of Electronic Publication: 2018 Oct 11.
Autor:
Verkade JMM; Synaffix BV, Industrielaan 63, 5349 AE Oss, The Netherlands. j.verkade@synaffix.com., Wijdeven MA; Synaffix BV, Industrielaan 63, 5349 AE Oss, The Netherlands. m.wijdeven@synaffix.com., Van Geel R; Synaffix BV, Industrielaan 63, 5349 AE Oss, The Netherlands. r.vangeel@synaffix.com., Janssen BMG; Synaffix BV, Industrielaan 63, 5349 AE Oss, The Netherlands. b.janssen@synaffix.com., Van Berkel SS; Synaffix BV, Industrielaan 63, 5349 AE Oss, The Netherlands. s.vanberkel@synaffix.com., Van Delft FL; Synaffix BV, Industrielaan 63, 5349 AE Oss, The Netherlands. f.vandelft@synaffix.com.
Publikováno v:
Antibodies (Basel, Switzerland) [Antibodies (Basel)] 2018 Aug 30; Vol. 7 (3). Date of Electronic Publication: 2018 Aug 30.
Autor:
Verkade JMM; Synaffix BV, Industrielaan 63, 5349 AE Oss, The Netherlands. j.verkade@synaffix.com., Wijdeven MA; Synaffix BV, Industrielaan 63, 5349 AE Oss, The Netherlands. m.wijdeven@synaffix.com., Van Geel R; Synaffix BV, Industrielaan 63, 5349 AE Oss, The Netherlands. r.vangeel@synaffix.com., Janssen BMG; Synaffix BV, Industrielaan 63, 5349 AE Oss, The Netherlands. b.janssen@synaffix.com., Van Berkel SS; Synaffix BV, Industrielaan 63, 5349 AE Oss, The Netherlands. s.vanberkel@synaffix.com., Van Delft FL; Synaffix BV, Industrielaan 63, 5349 AE Oss, The Netherlands. f.vandelft@synaffix.com.
Publikováno v:
Antibodies (Basel, Switzerland) [Antibodies (Basel)] 2018 Feb 20; Vol. 7 (1). Date of Electronic Publication: 2018 Feb 20.
Autor:
van Geel R; SynAffix BV , Pivot Park, Molenstraat 110, 5342 CC, Oss, The Netherlands., Wijdeven MA; SynAffix BV , Pivot Park, Molenstraat 110, 5342 CC, Oss, The Netherlands., Heesbeen R; SynAffix BV , Pivot Park, Molenstraat 110, 5342 CC, Oss, The Netherlands., Verkade JM; SynAffix BV , Pivot Park, Molenstraat 110, 5342 CC, Oss, The Netherlands., Wasiel AA; SynAffix BV , Pivot Park, Molenstraat 110, 5342 CC, Oss, The Netherlands., van Berkel SS; SynAffix BV , Pivot Park, Molenstraat 110, 5342 CC, Oss, The Netherlands., van Delft FL; SynAffix BV , Pivot Park, Molenstraat 110, 5342 CC, Oss, The Netherlands.
Publikováno v:
Bioconjugate chemistry [Bioconjug Chem] 2015 Nov 18; Vol. 26 (11), pp. 2233-42. Date of Electronic Publication: 2015 Jun 10.